Inspire Medical Systems ( (INSP) ) has provided an update.
Inspire Medical Systems reported a robust third quarter for 2024, with a 33% increase in revenue, reaching $203.2 million, and earnings per share of $0.60. The company expanded its U.S. operations by activating 66 new medical centers and creating 13 new sales territories. Inspire also raised its full-year revenue and earnings guidance due to strong business performance and FDA approval of its Inspire V neurostimulation system, reinforcing its position as a key player in treating obstructive sleep apnea.
For a thorough assessment of INSP stock, go to TipRanks’ Stock Analysis page.
